Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
309.6 INR | +1.24% | -0.47% | +23.95% |
May. 17 | Jefferies Adjusts Biocon’s Price Target to INR230 From INR250, Keeps at Underperform | MT |
May. 17 | Biocon's Consolidated Net Profit Declines in Fiscal Q4 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.95% | 4.37B | |
+9.58% | 115B | |
+12.41% | 107B | |
-3.14% | 21.6B | |
-12.38% | 22.31B | |
-5.71% | 19.19B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B |
- Stock Market
- Equities
- BIOCON Stock
- News Biocon Limited
- Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil